Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis C
hepatitis C
German Review Panel Sees Added Benefit for J&J Hepatitis C Drug
Bloomberg
Mon, 01/16/12 - 05:18 pm
JNJ
hepatitis C
Germany
Incivo
Telaprevir
Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says
Bloomberg
Sat, 01/14/12 - 11:28 am
Idenix
hepatitis C
IDX184
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen
Bloomberg
Tue, 01/10/12 - 09:45 am
Merck
hepatitis C
Victrelis
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
hepatitis C
Inhibitex
Bristol-Myers Squibb
Gilead
Pharmasset
M&A
Idenix reports positive interim data for HCV Nucleotide Inhibitor, IDX184
Yahoo/Fly on the Wall
Mon, 01/9/12 - 10:30 am
Idenix
hepatitis C
nucleotide inhibitor
IDX184
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bloomberg
Mon, 01/9/12 - 10:12 am
Bristol-Myers Squibb
M&A
Inhibitex
hepatitis C
Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Mon, 01/9/12 - 09:57 am
hepatitis C
Bristol-Myers Squibb
M&A
Inhibitex
Gilead
Pharmasset
Bristol to buy Inhibitex for hepatitis C treatment
Reuters
Sun, 01/8/12 - 12:45 pm
INX-189
Inhibitex
hepatitis C
Bristol-Myers Squibb
M&A
Inhibitex Shares Whipsawed by Cautious Analyst Comment
TheStreet.com
Wed, 01/4/12 - 03:14 pm
Inhibitex
hepatitis C
INX-189
Achillion's hepatitis C drug gets FDA fast track
Reuters
Wed, 01/4/12 - 09:25 am
Achillion
fast track
FDA
hepatitis C
ACH-1625
Interview: Vertex CEO concerned about investors' 'hyper-focus' on hep C
Fierce Biotech
Wed, 12/21/11 - 01:15 pm
hepatitis C
Vertex
Pharma CEOs
Matt Emmens
Health Care's Hottest Duo
Motley Fool
Wed, 12/21/11 - 09:01 am
Gilead
Pharmasset
hepatitis C
Achillion
Inhibitex
Safety (Still) Trumps Acquisitions in Hep C
Motley Fool
Sat, 12/17/11 - 11:31 am
hepatitis C
Inhibitex Shares Got Crushed: What You Need to Know
Motley Fool
Sat, 12/17/11 - 11:26 am
Inhibitex
INX-189
PSI-938
hepatitis C
Inhibitex, Idenix rattled by rival's drug failure
MarketWatch
Sat, 12/17/11 - 11:23 am
Inhibitex
Idenix
PSI-938
Pharmasset
hepatitis C
Hep C Drug Panic! Pharmasset Stumble Ripples Through Sector
TheStreet.com
Fri, 12/16/11 - 11:29 am
Pharmasset
hepatitis C
Gilead
Inhibitex
PSI-938
Indenix
Pharmasset Says Drug Trial Change Won’t Affect Gilead Takeover Agreement
Bloomberg
Fri, 12/16/11 - 11:26 am
Pharmasset
Gilead
M&A
hepatitis C
PSI-938
4 Reasons Inhibitex Is No Longer A Good Buy
Seeking Alpha
Wed, 12/7/11 - 11:42 am
Inhibitex
INX-189
Gilead
hepatitis C
Pharmasset
Dendreon to sell royalty in Merck hep C drug
Reuters
Tue, 12/6/11 - 04:30 pm
Merck
Dendreon
hepatitis C
Victrelis
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »